Name: Epsilon Healthcare (EPN) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

EPN

Pharmaceuticals, Biotechnology & Life Sciences

Epsilon Healthcare

Short interest: 0.01%; +0.01 pp 30d; as of 5 June 2023
Reported shorts: 22.2K
Shares on issue: 300.354M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Epsilon Healthcare

Epsilon Healthcare (EPN) is a diversified global healthcare and pharmaceuticals company operating in the ASX market. The company owns significant medicinal cannabis assets, including the largest cannabis manufacturing facility in the Southern Hemisphere, positioning it as a key player in this emerging sector. Beyond cannabis, EPN provides a range of medical equipment, supplies, and healthcare services, offering hi-tech products and turn-key solutions to the healthcare industry.

Company profile →

Epsilon Healthcare (ASX:EPN) has 0.01% of its shares on issue reported as short positions as of 5 June 2023, or about 22,217 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.24% in July 2021. EPN is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads EPN today

Zanger BreakoutWatchScore 31rank 573 of 1893
CAN SLIMWatchScore 24rank 476 of 1549
Minervini Trend TemplateWatchScore 27rank 628 of 1684
Crowded-Short BreakoutWatchScore 15rank 673 of 1448
Quality compoundersWatchScore 23rank 626 of 1660

Prices to 15 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

EPN fundamentals

In the half year to 30 Jun 2026, Epsilon Healthcare (ASX:EPN) recorded revenue of A$7.6M. Year-on-year growth: revenue +67.7% (FY). Net margin −13.6% (FY). Figures are in AUD, the company's reporting currency; source: Company filing (extracted) and Yahoo Finance, as at 10 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →